Napredna pretraga

Pregled bibliografske jedinice broj: 434490

The assessment of genotoxicity of a newly synthesized atropine-4-oxime on human lymphocytes in vitro


Lucić Vrdoljak, Ana; Berend, Suzana; Kopjar, Nevenka; Mladinić, Marin; Želježić, Davor; Lovrić, Jasna
The assessment of genotoxicity of a newly synthesized atropine-4-oxime on human lymphocytes in vitro // 7th Congress of the Toxicology in Developing Countries, Sun City, Južnoafrička Republika, Knjiga sažetaka
Sun City, Južnoafrička Republika, 2009. (poster, međunarodna recenzija, sažetak, znanstveni)


Naslov
The assessment of genotoxicity of a newly synthesized atropine-4-oxime on human lymphocytes in vitro

Autori
Lucić Vrdoljak, Ana ; Berend, Suzana ; Kopjar, Nevenka ; Mladinić, Marin ; Želježić, Davor ; Lovrić, Jasna

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
7th Congress of the Toxicology in Developing Countries, Sun City, Južnoafrička Republika, Knjiga sažetaka / - , 2009

Skup
7th Congress of the Toxicology in Developing Countries (7CTDC ; 2009)

Mjesto i datum
Sun City, Južnoafrička Republika, 06.-10.09.2009

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Atropine-4-oxime; genotoxicity; human lymphocytes

Sažetak
Present study aimed at the evaluation of genotoxicity of a newly synthesized substance with intriguing molecular structure in which an atropine part is coupled with oxime. Both atropine and oxime have important role in the management of acute cholinergic syndrome and are involved in the recovery of inhibited enzyme acetylcholinesterase (AChE). Preliminary studies on mice indicated that LD50 of the substance equals to 10 mg/kg. Here we evaluated the effects of doses that correspond to 5%LD50 and 1/4LD50. Study was performed on isolated human peripheral lymphocytes that were incubated in vitro for 30 min in the presence of test substance with and without metabolic activation. Lymphocyte viability, apoptosis/necrosis measurements, alkaline and neutral comet assay were performed immediately after the treatment. The results show that tested substance did not significantly impair the viability of lymphocytes. Metabolic activation slightly contributed to its toxicity only when administered at concentration of 5% LD50 and it was noticed as a non-significant increase of apoptotic cells. On the contrary, oxime applied in higher dose with metabolic activation significantly increased cell viability and decreased the incidence of necrotic cells. In the alkaline comet assay both tested concentrations evoked an increase in the tail intensity compared to negative control, but differences between samples with and without metabolic activation were not statistically significant. The results of neutral comet assay show that treatment with oxime in both tested concentrations did not significantly influence integrity of lymphocyte DNA. Taken together, the findings of this study indicate an acceptable genotoxic profile of atropine-oxime on human lymphocytes in vitro, but its activity should be further tested on other cell types and animal model to elucidate whether it is a source molecule promising for application in vivo as an efficient antidote in organophosphorus poisoning.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Projekt / tema
022-0222148-2137 - Genotoksičnost kemijskih i fizikalnih agensa prirodnog i antropogenog podrijetla (Vilena Kašuba, )
022-0222148-2139 - Terapijski učinak novosintetiziranih spojeva pri otrovanju organofosfatima (Ana Lucić Vrdoljak, )

Ustanove
Institut za medicinska istraživanja i medicinu rada, Zagreb